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Background: The human chromosome 19 miRNA cluster (C19MC) of 43 genes is a primate-specific miRNA cluster
that may have biological significance in the genetic complexity of the primate. Despite previous reports on individual
C19MC miRNA expression in cancer and stem cells, systematic studies on C19MC miRNA expression and biological
functions are lacking.
Results: Cluster-wide C19MC miRNA expression profiling by microarray analysis showed wholesome C19MC activation in
embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs). However, in multipotent adipose-derived
mesenchymal stem cells (MSCs) and a unipotent human white pre-adipocyte cell line, only selected C19MC miRNAs were
expressed. MiRNA copy number analysis also showed selective C19MC expression in cancer cells with expression patterns
highly similar to those in MSCs, suggesting similar miRNA regulatory mechanisms in these cells. Selective miRNA
expression also suggests complex transcriptional mechanism(s) regulating C19MC expression under specific cellular and
pathological conditions. Bioinformatics analysis showed that sixteen of the C19MC miRNAs share the same “AAGUGC”
seed sequence with members of the miR-302/-372 family, which are known cellular reprogramming factors. In particular,
C19MC-AAGUGC-miRNAs with the nucleotides 2-7 canonical seed position as in miR-302/-372 miRNAs, may play similar
roles as miR-302/-372 in induced pluripotency. A biased 3p-arm selection of the C19MC-AAGUGC-miRNAs was observed
indicating that targets of the 3p species of these miRNAs may be biologically significant in regulating stemness.
Furthermore, bioinformatics analysis of the putative targets of the C19MC-AAGUGC-miRNAs predicted significant
involvement of signaling pathways in reprogramming, many of which contribute to promoting apoptosis by indirect
activation of the pro-apoptotic proteins BAK/BAX via suppression of genes of the cell survival pathways, or by enhancing
caspase-8 activation through targeting inhibitors of TRAIL-inducing apoptosis.
Conclusions: This work demonstrated selective C19MC expression in MSCs and cancer cells, and, through miRNA
profiling and bioinformatics analysis, predicted C19MC modulation of apoptosis in induced pluripotency and
tumorigenesis.
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MicroRNAs (miRNAs) are short noncoding single-
stranded RNAs that act post-transcriptionally as negative
regulators of gene expression. In the miRNA biogenesis
process, either or both 5p and 3p miRNA species may
be generated from the pre-miRNA precursor arms [1, 2].
Selective maturation or co-existence of the 5p and 3p
species is biologically important since they target differ-
ent gene sets. MiRNAs also form family groups defined
by short homologous sequences, called the seed sequence,
which is located at the 5’- end of the mature miRNAs.
MiRNAs of the same family often form functionally-
related groups that cross-regulate targets to ensure con-
servation of biological functions [3, 4].
miRNAs are involved in regulating developmental pat-
terning, maintenance of stem cell self-renewal and can-
cer progression [5, 6]. Specific miRNAs are up-regulated
in pluripotent stem cell population but not in mature
differentiated cell types in early embryonic development
[7]. Specific miRNAs have also been shown to be able to
reprogram somatic cells to induced pluripotent stem
cells (iPSCs) [8, 9]. MiR-302-driven cellular reprogram-
ming coordinates stem cell division by regulating targets
in the cell cycle, particularly at the G1/S restriction point
[5]. Besides the roles in stem cell biology, miRNAs also
act as tumor suppressors or oncogenes in the tumorigen-
esis process [10–14]. Thus, aberrant expression of miRNA
affects crucial processes in the development and progres-
sion of tumors, including induction of anti-apoptosis, de-
velopment of drug resistance and cancer invasion and
metastasis [15–22].
For regulatory advantages, miRNAs, particular those
from the same family, are often clustered in specific
chromosomal locations [23]. One such human miRNA
cluster is mapped on chromosome 19, and is called the
chromosome 19 miRNA cluster, or C19MC [24]. C19MC,
one of the largest miRNA gene clusters in the human
genome, contains 46 highly homologous miRNA genes,
including 7 duplicated pairs of the same genes, within a
~100-kb genomic region. Importantly, C19MC is a
primate-specific miRNA cluster that appeared late in
the evolution of the primate lineage; bioinformatics ana-
lysis has predicted that C19MC miRNAs play critical roles
in reproduction, development and differentiation in the
primate compared to the lower vertebrates [25].
Reproduction-related role of C19MC is further reflected
in its restrictive expression in reproductive tissues, but not
in other adult organs and tissues; C19MC expression has
also been shown in pluripotent embryonic stem cells
(ESCs) [7, 11, 25]. In the human placenta, C19MC is
expressed en bloc from the paternal allele governed by
a major promoter located 17.6 kb upstream of the first
miRNA gene in the cluster [26]. Transcription of the
C19MC cluster was further suggested to be mediatedby demethylation of the upstream CpG-rich master
promoter region to first generate a primary transcript
encompassing the entire C19MC gene cluster, followed
by splicing to generate the individual precursor miRNA
species, and subsequently processed by the DGCR8-
Drosha microprocessor complex to generate individual
mature miRNAs [24]. The implication of a master pro-
moter mode of transcription is the all-or-none presence
of C19MC miRNAs in the expressed cells. At present,
the biological functions and expression patterns of C19MC
members in other stem cell types and in cancer cells have
not been systematically examined in a cluster-wide manner.
In a previous study, we reported genome-wide miRNA
profiling analysis of ESCs, iPSCs and mesenchymal stem
cells (MSCs), proposing cross- and co-regulation by 5p
and 3p paired miRNA species during reprogramming
[4]. Using the same miRNA microarray profiling dataset,
we focused in this work on the expression profiles of
C19MC miRNAs in various stem cell types and in cancer
cells. Possible biological functions of a subset of miR-
302-like C19MC miRNAs, were further investigated by
bioinformatics analysis, which predicted targeting at the
apoptosis pathway in the tumorigenesis of cancer cells
and induced pluripotency in stem cells.
Methods
Cell lines
We have previously described iPSC lines derived from
two MSCs, namely adipose stem cell (ASC; Invitrogen,
Carlsbad, CA, USA) and human adipose-derived MSC
(MSC-AT; PromoCell, Heidelberg, Germany), and from
a human white pre-adipocyte (HWP) cell line [4, 27]. In
this work, human adipose-derived MSC, designated ASC
Lonza, was purchased from Lonza, Lonza, Verviers, Belgium.
MH#1 was an iPSC cell lined established from ASC
Lonza in our lab (S. Sugii, unpublished data). WJ0706
is a human MSC cell line derived from Wharton’s Jelly
(WJ) obtained from Cytopeutics Sdn. Bhd, Selangor,
Malaysia (http://www.cytopeutics.com). The MSC cell
lines were isolated and characterized at Cytopeutics ac-
cording to standard procedures and with ethical clear-
ance [28]. Human placenta choriocarcinoma cell line
JEG-3 (ATCC HTB-36), human normal placental cell
line HS 799. PI (ATCC CRL-7530) and human normal
colon cell line CRL-1790 (ATCC CRL-1790) were pur-
chased from ATCC (Manassas, VA, USA). Cancer cell
lines were kindly provided by Professor Y.M. Lim, Cancer
Research Center, Universiti Tunku Abdul Rahman.
miRNA microarray profiling
Total RNA was isolated from the cell lines by using the
MiRNeasy Mini Kit (Qiagen, USA) according to the
manufacturer’s manual. Microarray analysis was performed
using the SmartChip Human MicroRNA Panel version 3.0
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1036 unique real-time PCR reactions in quadruplicates as
previously described [4]. To identify differentially expressed
miRNAs, the iPSC data were compared with data of the
parental MSC or HWP cells from which they were de-
rived. For calculation of expression levels, the All-Mean
Normalization method was employed, where mean Ct
values of all expressed genes were used. To compute
the expression levels of expressed miRNAs, the Ct
values of each sample were compared to its average Ct
(All-Mean) to obtain the ΔCt values. ΔΔCt was then
calculated by the two ΔCt values between the iPSC and
its parental cells. Log2(fold change), or log2(FC), was
computed as log2[FC (2
-ΔΔCt)]. The selection criteria for dif-
ferentially expressed miRNA was log2(FC) > 1.5 or < -1.5,
with p < 0.05 as determined by the Student’s t test.
Reverse transcription and miRNA real-time PCR assays
RNA was reverse-transcribed using the TaqMan Micro-
RNA Reverse Transcription Kit and miRNA-specific
stem-loop primers (Applied Biosystems, USA). The re-
verse transcription reaction was as follows: 0.075 μl of
100 mM dNTP, 0.5 μl RT enzyme (50 U/μl), 0.75 μl 10X
RT buffer, 0.094 μl RNAse inhibitor (20 U/μl), 50 ng
RNA. Reaction conditions were 16 °C for 30 min, 42 °C
for 30 min, 85 °C for 5 min, and held at 4 °C. Real-time
PCR assays of the transcribed cDNA were performed
using the TaqMan MicroRNA assays (Applied Biosystems,
USA). The reaction mixture was as follows: 10 μl TaqMan
2X universal PCR master mix, 1 μl 20X TaqMan Micro-
RNA Assay, 1.33 μl cDNA and 7.67 μl nuclease-free water.
Reaction conditions were: 95 °C for 10 min, followed by
40 cycles at 95 °C for 15 s, and 60 °C for 1 min.
Determination of absolute copy number of mature miRNAs
Synthetic mature miRNAs (Integrated DNA Technologies
IDT, Coralville, IA, USA) were serially diluted to final con-
centrations of 200 nM, 20 nM, 2 nM, 0.2 nM, 0.02 nM, 2
pM, 0.2 pM and 0.02 pM. Serially-diluted synthetic RNAs
were reverse-transcribed and subjected to real-time PCR
analysis concurrently with the sample RNAs. Standard
curves were included on each plate of the miRNA Taq-
Man assays to convert the cycle threshold (Ct) values of
each sample into the corresponding number of miRNA
copies in each cell, assuming that each cell contains
15 pg total RNA, as previously described [29]. Ct
values ≥ 35 indicated that their expression levels were
too low for accurate analysis, and were considered no
detectable expression. The cut-off threshold of miRNA
expression was, therefore, standardized at Ct < 35.
Construction of phylogeny tree
The stem-loop sequences for C19MC were downloaded
from miRBase ver. 21. A phylogenetic tree wasgenerated by multiple sequence alignment using the
Clustal method of the Megalign project provided by
DNAstar® (Salt Lake City, Utah, USA).
Prediction of miRNA target genes
miRNA:mRNA interactions were predicted using the
major miRNA databases TargetScan and microRNA.org.
To identify genes and pathways targeted specifically by
selected C19MC-AAGUGC-miRNAs, overlapping target
gene sets of the selected miRNAs were used for the
Kyoto Encyclopedia of Genes and Genomes (KEGG) path-
way and Gene Ontology (GO) annotation analysis based
on the web-based DAVID (Database for Annotation,
Visualization and Integrated) algorithm. The criteria of
analysis was EASE score ≤ 0.05, in which EASE score is a
modified Fisher Exact P value in the DAVID system used
for gene-enrichment analysis. An EASE score P value = 0
represents perfect enrichment; P value ≤ 0.05 was consid-
ered as significant gene-enrichment in a specific annota-
tion category.
Results
Selective activation of C19MC miRNAs in mesenchymal
stem cells
We have previously reported genome-wide miRNA ex-
pression profiling of two ESCs, two multipotent adipose-
derived MSCs, a unipotent HWP cell line, and the three
iPSC lines derived from the MSCs and HWP [4]. In this
study, the expression data of C19MC miRNAs in the
MSCs and HWP, and the MSC- and HWP-derived iPSCs
were extracted for further analysis. Our results showed
that all the forty-five C19MC miRNAs included in the
microarray in either the 5p or 3p or in both 5p/3p con-
figurations were expressed, albeit to different extents, in
all the three pluripotent iPSC cell lines tested (Table 1),
and in the hESC controls (data not shown). The miR-372
family that lies adjacent to the C19MC cluster (Fig. 1a)
was also included in the analysis since they have been
reported to be expressed in pluripotent stem cells [9].
Of the forty-five C19MC miRNAs, thirty-nine were sig-
nificantly (p < 0.05) expressed, as previously reported
[7]. Expression of the C19MC miRNAs in the iPSCs
was generally two-fold or greater than that in the par-
ental cell lines; the highest level of expression was
8.375 log2(fold change) in miR-520b (Table 1). Notably,
both the 5p and 3p miRNA species were expressed in
most cases; otherwise, the 3p species was the favored
precursor arm selected for the mature miRNAs, as op-
posed to frequent 5p arm expression in most other
miRNA genes [2].
On the other hand, only selected C19MC miRNAs were
found to be expressed in MSC and HWP (Tables 1 and 2).
Many of the expressed miRNAs share the “AAGUGC”
seed sequence of the known reprogramming miR-302
Table 1 Expression of C19MC and the miR-372 family miRNAs
in stem cells
miRNAa Gene copy Expressionb Log2(fold change)
HWP MSC iPSC
miR-512-5p 2 - +/- + 5.265 ± 0.58**
miR-512-3p + + + 3.600 ± 1.85*
miR-1323 (5p) 1 - - + 7.319 ± 0.50**
miR-498 (5p) 1 + + + 3.857 ± 0.99**
miR-520e (3p) 1 - - + 4.001 ± 0.20**
miR-515-5p 2 - - + 7.053 ± 0.63**
miR-515-3p - - + 4.083 ± 0.45**
miR-519e-5p 1 - - + 3.046 ± 0.55**
miR-519e-3p - - + 3.320 ± 0.44**
miR-520f-3p 1 - - + 6.275 ± 0.75**
miR-519c-3p 1 - - + 5.685 ± 0.66**
miR-1283 (5p) 2 - - + 3.055 ± 0.29**
miR-520a-5p 1 - - + 4.863 ± 0.71**
miR-520a-3p + + + 0.869 ± 1.48
miR-526b-5p 1 - + + 4.233 ± 0.13*
miR-526b-3p - +/- + 6.906 ± 0.81**
miR-519b-3p 1 - + + 2.620 ± 1.36*
miR-518f-5p 1 - +/- + 3.901 ± 0.50**
miR-518f-3p - +/- + 6.971 ± 0.59**
miR-520b (3p) 1 - - + 8.375 ± 0.54**
miR-518b (3p) 1 + + + 3.706 ± 0.98*
miR-526a (5p) 2 - + + 2.741 ± 1.95
miR-520c-3p 1 - - + 8.285 ± 0.70**
miR-518c-5p 1 n.d. - + 4.135 ± 0.34
miR-518c-3p - - + 6.282 ± 0.76**
miR-524-5p 1 - - + 3.810 ± 0.60**
miR-524-3p - - + 4.202 ± 0.63**
miR-517a-5p 1 - +/- + 2.328 ± 0.65*
miR-517a-3p - - + 8.262 ± 0.62**
miR-519d-3p 1 - +/- + 4.819 ± 2.56*
miR-521 (3p) 2 + + + 1.500 ± 0.30*
miR-520d-5p 1 - - + 3.933 ± 0.34**
miR-520d-3p n.d. + + 0.233 ± 3.93
miR-517b-3p 1 - +/- + 6.474 ± 0.73**
miR-520g-3p 1 + + + 6.014 ± 1.27**
miR-516b-5p 2 - - + 3.243 ± 0.52
miR-518e-5p 1 - + + 3.344 ± 1.88
miR-518e-3p + + + 1.386 ± 0.49*
miR-518a-3p 2 + + + 2.013 ± 1.04*
miR-518d-3p 1 - - + 3.613 ± 0.47**
miR-520h (3p) 1 - + + 5.618 ± 0.82**
miR-522-3p 1 - - + 4.060 ± 0.47**
Table 1 Expression of C19MC and the miR-372 family miRNAs
in stem cells (Continued)
miR-519a-3p 2 - - + 6.586 ± 0.56**
miR-516a-5p 2 - - + 3.583 ± 0.32**
miR-516a-3p - +/- + 0.758 ± 0.52*
miR-371a-5p 1 - - + 6.256 ± 1.14**
miR-372a-3p + +/- + 1.094 ± 5.34
miR-372-3p 1 + + + 7.201 ± 0.11**
miR-373-5p 1 - - + 2.500 ± 1.27*
miR-373-3p - - + 7.240 ± 1.39**
amiRNA-5p and -3p designations are based on miRBase ver. 21; -5p and -3p
designations in brackets are not annotated in miRBase, but are the presumptive
precursor arms derived from sequence alignment. miRNAs are arranged in order
of relative physical locations on chromosomae 19.13q.41; the neighbouring miR-
371-3 cluster is also shown. bThe two MSC cell lines were used in comparison
with the three iPSC lines derived. “+” and “-” indicate detectable and undetect-
able expression of the miRNA, respectively, in both cell lines; “+/-” indicates that
one of the two MSC was positive and the other one was negative. n.d. not done
*p < 0.05, **p < 0.01
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AAGUGC-miRNAs in this work (see Fig. 2a and depiction
below). Twenty-two (48.9%) of the forty-five C19MC
miRNAs were activated in one or both MSC cell lines.
Only eight miRNAs were expressed in HWP, which
were, interestingly, also all expressed in the two MSC
and all pluripotent cells (Table 2). This may suggest
that these eight miRNAs constitute the minimal miRNA
set require for minimal potency in the unipotent HWP.
Thus, the cluster-wide microarray results indicated se-
lective activation of twenty-two C19MC miRNAs in
multipotent mesenchymal stem cells.
It has been reported that C19MC miRNAs are not
expressed in adult tissues except in tissues of the repro-
ductive system [11]. To obtain further supporting evi-
dences on selective activation, expression of eight
miRNAs spanning the C19MC cluster (Fig. 1a), but with
different genomic structures, was selected for further ex-
perimentally verification; amongst the selected miRNAs,
miR-512-3p is transcribed by the two miR-512-1 and-
512-2 genes located at the 5’-end of the C19MC miRNA
gene cluster; miR-520c-3p, -519b-3p and -520f-3p are
single miRNA genes located between previously proposed
exons; miR-524-5p and -517a-3p are two of three
miRNA genes mapped on intron 18 and miR520d-5p
and -520g-3p are two of four miRNAs mapped on in-
tron 20 (Fig. 1a) [24]. Verification was done in three
other different MSC cell lines, namely the MSC cell line
WJ0706 derived from the Wharton’s Jelly [28], and two
other adipose-derived MSC cell lines, ASC-Inv and
ASC Lonza (Fig. 1b). In the experiments, two other adi-
pose MSC-derived iPSCs, ASC-iPSC and MH#1, and
two hESCs, H6 and H9, were included. The miRNA ex-
pression levels were determined as the absolute miRNA
transcript copy number per cell, which ranged from 0
Fig. 1 Expression of selected C19MC miRNAs in different cell lines. a A scheme displaying relative genomic locations of the C19MC and the miR-372
family miRNAs on human chromosome 19q13.41. MiRNAs in green and blue boxes harbor the AAGUGC seed sequence in the canonical (nts 2-7) or
non-canonical positions, respectively (see Fig. 2a). The proposed exon sequences (Ex) of the clusters (Bortolin-Cavaille et al. [24]) are shown in short
gray bars between the miRNAs; introns (Int) 18 and 20 shown carry two of multiple miRNA genes analyzed. The eight C19MC miRNAs selected for
expression analysis in (b) and (c) below are shown in bold, with the expression A-C grouping designations established in (b) and (c) shown at
the bottom of the miRNAs. b Expression of selected C19MC miRNAs, determined based on copy number per cell, in mesenchymal stem cells
(MSCs). The MSCs included are: MSC-AT, WJ0706, ASC-INV and ASC. ASC IPSC and MH#1 are iPSCs derived from ASC-INV and ASC Lonza, respectively.
H6 and H9 are human ESC cell lines. c C19MC miRNA expression in cancer cells. The cell lines used are: CRL-1790: normal colon cells, Hs799. PI: normal
placenta cells, HCT15 and SK-CO-1: colorectal cancer cells; HepG2: hepatocellular carcinoma cells, MCF7: breast cancer cells; JEG3: choriocarcinoma cells.
Ct values≥ 35 was used as the cut-off threshold in the analysis
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to 377,200 copies per cell at a Ct value of 25.7 in
miR-520g-3p in ESC H9 cells (Fig. 1b).
Consistent with the miRNA microarray results, the se-
lected miRNAs were all expressed to different levels in
all four iPSCs and ESCs (Fig. 1b). In contrast, the tested
miRNAs were either not expressed, or expressed todifferent but lower levels in the MSCs tested. MSC ex-
pression of the eight C19MC miRNAs could be grouped
in three expression patterns: group A, which included
miR-512-3p and -520c-3p, showed very low or undetect-
able expression in the MSCs; expression of the group B
miR-520d-5p, 519b-3p and -524-5p was detected in at
least one or both MSC cell lines, whereas miR-520f-3p,
Table 2 Expression of C19MC miRNAs in different stem cell types
Stem cell type Potency miRNAa No.
AAGUGC seed sequenceb Others
iPSC/hESC Pluripotent 16 miRNAs 29 miRNAs 45
MSC Multipotent
One cell line miR-519d-3p, miR-526b-3p miR-512-5p, miR-516a-3p, miR-517a-5p,
miR-517b-3p, miR-518f-5p, miR-518f-3p
8
Both cell lines miR-512-3p, miR-519b-3p, miR-520a-3p,
miR-520d-3p, miR-520g-3p, miR520h
miR-498, miR-518a-3p, miR-518b, miR-518e-5p,
miR-518e-3p, miR-521, miR-526a, miR-526b-5p
14
HWP Unipotent miR-520a-3p, miR-520g-3p, miR-512-3p miR-498, miR-518a-3p, miR-518b, miR-518e-3p,
miR-521
8
All cell lines Pluri-/multi-/unipotent miR-520a-3p, miR-520g-3p miR-498, miR-512-3p, miR-518a-3p, miR-518b,
miR-518e-3p, miR-521
8
amiRNAs in bold letters were used for further quantification as depicted in Fig. 1. bAAGUGC seed sequence-containing miRNAs are taken from Fig. 2
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three MSC cell lines (Fig. 1b and Table 2). The collective
results obtained from the microarray and real-time RT-
PCR experiments, therefore, confirmed selective C19MC
expression in multipotent MSCs, and en bloc expression
in pluripotent iPSCs. Furthermore, there seemed to be no
correlation between the expression pattern and the phys-
ical location of the miRNA genes tested (Fig. 1a). Notably,
the miR-524-5p and -517a-3p and the miR520d-5p and
-520g-3p couples are flanked by two proposed exons butFig. 2 C19MC miRNAs harboring the AAGUGC hexameric sequence. a The
sequence (in bold letters and boxed in red) with the miR-302 (in blue letters
the AAGUGC seed sequence in the canonical nucleotides 2-7 position are c
II, with IIa and IIb subgroups as depicted. *miRNAs are in the 3p configurat
on computational prediction. b Phylogenic tree of all C19MC miRNAs reco
AAGUGC-harboring miRNAs as defined in (b) above (see text for further debelong to different expression groups B and C (Fig. 1a).
The data suggest regulation by different promoters or
transcriptional regulatory mechanism(s) other than simple
splicing of the two flanking exon and co-processing of the
spliced intron sequence as previously proposed for
C19MC expression in a choriocarcinoma JEG-3 cell line
[24]. The observation further suggests a critical biological
role of the expressed C19MC miRNA in conferring differ-
ent degrees of stemness to the stem cells, particularly in
MSCs.sixteen C19MC miRNAs that share the AAGUGC hexameric seed
) and miR-372 (in green letters) families are shown. MiRNAs that have
alled group I; other miRNAs in non-canonical position are called group
ion as in the miRBase ver 21. **The existence of miR-1323-3p is based
nstructed with the precursors of the miRNAs. Groups I, IIa and IIb are
scription)
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Previous reports have indicated frequent activation of
C19MC miRNAs in different cancer types, including
colorectal cancer, breast cancer and primitive neuroecto-
dermal brain tumor [13, 30, 31] (see below). To investi-
gate C19MC expression in cancer cells, the expression
of the same set of eight C19MC miRNAs was also quan-
tified as gene copy number per cell in two colorectal
cancer (HCT15 and SKCO1), one breast cancer (MCF-7)
and one hepatocellular carcinoma (HepG2) cell lines; the
choriocarcinoma (JEG-3) cell line, which was derived from
the reproductive system, was included a positive control
since JEG-3 cells have been shown to express all C19MC
miRNAs in high levels [26] (Fig. 1c). Two cell lines
CRL-1790 and HS799. PI, derived from normal colon
and placenta tissues, respectively, were also included in
the analysis. Despite en bloc and high-level C19MC ex-
pression in JEG-3 cells, only four of the eight miRNAs,
namely miR-520d-5p of Group B as defined above for
stem cell expression, and all three Group C miRNAs,
miR-520f-3p, -517a-3p and -520g-3p, were shown to be
expressed in the normal placenta cell line Hs799. PI.
Furthermore, expression of the Group B miR-524-5p, and
all three Group C miRNAs was detected in CRL-1790,
which was derived from normal fetal colon epithelium
(Fig. 1c). The observed expression of selective C19MC in
fetal colon epithelium and in the placenta is consistent
with previous conclusions that C19MC is specifically
expressed in reproduction and developmental process-
related tissues and is silenced in normal tissues [7, 11, 25].
Interestingly, in the five cancer cell lines examined, the se-
lective expression patterns of the eight miRNAs was simi-
lar those shown in MSCs above (Fig. 1b). Group A
miRNAs also showed very low or undetectable expression
in normal and cancer cells, except in JEG-3, whereas the
Group B miRNAs were detected in one or more cancer
cell lines; all three Group C miRNAs were expressed all
four cancer cell lines (Fig. 1c). Taken together, quantitative
expression analysis showed highly similar C19MC miRNA
expression profiles found in MSCs and cancer cells, sug-
gesting that the C19MC miRNAs may share some similar
molecular and biological features in transcriptional regula-
tion and in the etiological pathways in acquiring multipo-
tency and cancer phenotype.
Identification of C19MC miRNAs harboring the “AAGUGC”
seed sequence
miRNA-mRNA interactions involve the seed region at
the 5’ end of the miRNA; hence, seed sequences are
important predictors for the identification of miRNA-
targeted transcripts [1]. MiRNAs that share a common
seed sequence also might share target specificity and
possibly biological functions. On sequence alignment,
sixteen C19MC miRNAs were found to share the sameseed sequence, 5’-AAGUGC-3’, with the reported
reprogramming-able miR-302 and miR-372 miRNA
families [8, 9] (Fig. 2a). These miRNAs are designated
as “C19MC-AAGUGC-miRNAs”. Furthermore, it is noted
that the AAGUGC seed position at 5’ end is variable
among the C19MC-AAGUGC-miRNAs: subgroup I
miRNAs, which includes eight miR-519 and -520 sub-
families, have the seed sequence located at the canonical
and optimal 5’-nucleotide positions (nts) 2-7, as in the
miR-302/-372 families; the seed sequence of the four sub-
group IIa miRNAs is at location nts 1-6, and that of the
remaining subgroup IIb miRNAs is at nts 3-8 and 4-9
(Fig. 2a). Hence, despite the presence of the AAGUGC
seed sequence, it is more likely that the nts 2-7 canonical
subgroup of the C19MC-AAGUGC-miRNAs may target
genes that share similar functions as the miR-302/-372
miRNAs.
While the 5p arm of a pre-miRNA precursor is nor-
mally selected for maturation [2], it is noted that the
C19MC-AAGUGC-miRNAs are predominantly derived
from the 3p arm of the precursor miRNAs, hinting at an
evolutionary bias in 3p selection with possible biological
implications. Further supporting evidence of conservation
of the C19MC-AAGUGC-miRNAs was derived from the
construction of a phylogenetic tree of all precursor se-
quences of the C19MC miRNAs (Fig. 2b). Most C19MC-
AAGUGC-miRNAs are grouped into the same cluster
in the top half of the phylogenetic tree. Four of the
remaining C19MC-AAGUGC-miRNAs form another
cluster in the middle of the tree and the remaining two
miRNAs are scattered in different branches in the lower
half of the tree (Fig. 2b).
Bioinformatics predictions of possible biological functions
of group I C19MC-AAGUGC-miRNAs
It is noted that the C19MC-AAGUGC-miRNAs with the
canonical nts 2-7 seed position, defined here as Group I
(Fig. 2), contributed more significantly in gene targeting.
Thus, in this study, we focused on analysis of potential
biological functions of C19MC-AAGUGC-miRNAs in
group I. Bioinformatics searches showed a total of 2058
putative target genes targeted by group I C19MC-
AAGUGC-miRNAs (Fig. 3a and Additional file 1: Table S1).
However, construction of a Venn diagram showed that
only 262 putative target genes are common between
the miR-519 and miR-520 subfamilies in group I, indi-
cating that the miR-519 and -520 subfamilies target dif-
ferent sets of genes. The overlapping gene sets among
miR-302/372 and the miR-519 and miR-520 subfamilies
in group I were further compared (Fig. 3a). The results
showed that 1185 putative shared genes were obtained
between the miR-520 and -302/372 families (Fig. 3a, blue
box and Additional file 1: Table S1), suggesting that
the miR-520 subfamily might share similar biological
Fig. 3 Bioinformatics analysis of predicted target genes of group I of the C19MC-AAGUGC-miRNAs. a Venn diagrams of predicted target genes of
the miR-302/372 families and group I of the C19MC-AAGUGC-miRNAs. (left panel) The miR-519 and -520 subfamilies share only a small number of
target genes. (right panel) The miR-520 miRNAs share a significant number of target genes with the miR-302/372 families. b & c The top 10 highest
scores and the most significantly enriched GO terms associated with biological process and molecular function, respectively. d Fourteen of the 24 most
enriched KEGG pathways displaying the ten signaling pathways identified; see text for explanation and Additional file 2: Table S2 for full list.
The numerical in brackets shows the ranking of each pathway
Nguyen et al. Journal of Biomedical Science  (2017) 24:20 Page 8 of 14functions with the miR-302/372 family. The group I
miR-519 subfamily also shares 262 putative target
genes with the miR-302/-372 families, far fewer than
the miR-520 subfamily (Fig. 3a, red box). Consistent
with the bioinformatics prediction, a literature review
showed that a number of validated targets have indeed
been reported to be shared between the miR-302/372
and the group I C19MC-AAGCGU-miRNA families
(Table 3).The 2058 putative target genes were further subjected
to GO analysis and KEGG pathway annotation (Fig. 3b-d).
Of the 828 predicted targets in the top 10 GO terms in
biological functions, 616 (74.4%) putative genes are associ-
ated with transcriptional and translational regulation of
gene expression (Fig. 3b, GO terms 1, 2, 4, 5, 7 & 8). The
remaining predicted targets regulate apoptosis, nervous
system development, cellular response to DNA damage
stimulus and cell cycle. The majority of the 2058 predicted
Table 3 Common validated target genes shared between the C19MC-AAGUGC-miRNAs and the miR-302/-372 families
AAGUGC-miRNA Seed positiona Target transcript References
miR-302/-372 C19MC
miR-302c miR-520e I NIK [10, 15]
miR-373 miR-520c I MT1-MMP, mTOR, SIRT1 [14, 21]
miR-372, -373 miR-520c, -520e I RelA [12]
miR-302b, -372, -373 miR-520c, -520e I TGFβR2 [9, 12]
miR-520b, -520e I CD46 [16]
miR-302c miR-520c I MICA, MICB, ULBP2 [17]
miR-519a I RBL2 [13]
miR-512 IIa
miR-519d, -520g IIb SMAD7 [19, 20]
miR-520g, -520h IIb DAPK2 [18, 22]
miR-302d, -372 miR-520b, -519b-3p, -520a-3p I CDKN1A [5, 6]
miR-519e IIa
miR-519d, -520h IIb
aGroup I seed position is the canonical nts 2-7; IIa is nts 1-6 and IIb is other non-canonical position, as defined in Fig. 2a
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ciated with transcriptional and translational regulation in
some way (Fig. 3c), and in epigenetic regulation (Fig. 3c,
GO term 9). Four hundred eleven genes (20.0%) are re-
lated to metal or zinc ion binding (Fig. 3c, GO terms 2
& 4). which may also be components of signaling path-
ways. Taken together, the GO analysis data suggested
that the group I C19MC-AAGUGC-miRNAs are mainly
associated with the regulation of gene expression, cell pro-
liferation and apoptosis via various signaling pathways.
The regulatory pathways were further annotated by in-
terrogation of the KEGG database, which yielded 24
pathways, which included 568 genes in total (Additional
file 2: Table S2); 14 of the 24 KEGG pathways which
may be related to pluripotency and cancer are shown in
Fig. 3d. Ten of the 24 pathways, which included 260
(45.8%) genes, are different signaling pathways that are
known to be involved in the growth and development
processes [9, 10, 12, 21, 32–36]. Notably, 129 (22.7%)
genes are associated with pathways regulating apoptosis
including PI3K-AKT, MAPK, HIF-1 and TNF (Fig. 3d;
see also Fig. 4 and Discussion below). The highest-
enriched PI3K-Akt signaling pathway (56 genes) regu-
lates cell survival by reducing apoptosis, stimulating cell
growth and increasing proliferation [36]. Furthermore,
many of the genes are related to pathways that regulate
the cell cycle (22 genes) and apoptosis (13 genes) (Fig. 3d),
which are important cellular events in the initiation and
maintenance of stem cell pluripotency and tumorigenesis.
Possible group I C19MC-AAGUGC-miRNAs targeting of
the pro-apoptosis functions in the survival pathway
Suppression of apoptosis is an important feature of the
initiate phase of the reprogramming process [37]. Onthe other hand, apoptosis dysregulation is associated with
the different stages of tumorigenesis, including initiation,
progression and metastasis [38]. A database search
showed that the group I C19MC-AAGUGC-miRNAs
target 179 apoptosis-associated genes (Additional file 3:
Table S3). On the other hand, the KEGG pathway ana-
lysis above (Fig. 3d) has also revealed that the highest
number of putative target genes of group I miRNAs are
associated with PI3K-Akt, a survival pathway. Hence,
we hypothesized that the group I miRNAs acted more
specifically to inhibit apoptosis by targeting survival-related
genes. Fifteen survival-related genes were predicted targets
of the group I miRNAs (Table 4). Two out of the fifteen
genes, viz. NIK and RelA, have been experimentally val-
idated as direct targets miR-520e and miR-520c-3p [10, 12].
Importantly, the group I miRNAs may promote apoptosis
either by indirectly activating pro-apoptotic proteins
BAK/BAX through suppression of the cell survival-related
genes [39], or by enhancing caspase-8 activation through
targeting inhibitors of TRAIL-inducing apoptosis [40, 41].
Taken together, the group I C19MC-AAGUGC-miRNAs
were predicted by bioinformatics analysis to regulate
apoptosis, which is important in the initial phase of cel-
lular reprogramming, and in particular the cell survival
pathways, which are directly relevant to tumorigenesis
processes.
Discussion
Selective C19MC miRNA expression in MSC and in cancer
cells suggests a complex transcriptional regulatory
mechanism
In the present study and in the literature, data showed
similar and disperse expression patterns of eight tested
C19MC miRNAs in both mesenchymal stem and cancer
Table 4 Predicted group I C19MC-AAGUGC-miRNA target genes
associated with cell survival pathways
Gene Symbol Gene name
AKT1 AKT serine/threonine kinase 1
IGF1 Insulin-like growth factor 1 (somatomedin C)
IL2 Interleukin 2
KIT KIT proto-oncogene receptor tyrosine kinase
MALT1 Mucosa associated lymphoid tissue lymphoma
translocation gene 1
NIK/MAP3K14a Mitogen-activated protein kinase kinase kinase 14
PIK3CA Phosphoinositide-3-kinase, catalytic, alpha
polypeptide
RELAa V-rel reticuloendotheliosis viral oncogene
homolog A (avian)
SOS1 SOS Ras/Rac guanine nucleotide exchange factor 1
TAK1/MAP3K7 Nuclear receptor subfamily 2 group C member 2
TLR4 Toll-like receptor 4
TNF/TNFα Tumor necrosis factor (TNF superfamily, member 2)
TNFRSF10D/DcR2 Tumor necrosis factor receptor superfamily, member
10d, decoy with truncated death domain
TRAF6 TNF receptor-associated factor 6
TSP-1/THBS1 Thrombospondin 1
aExperimentally validated target genes (Keklikoglou et al. [12]; Zhang et al. [10])
Fig. 4 A proposed scheme that links the predicted group I C19MC-AAGUGC-miRNAs-targeted genes (in color boxes) to cell survival functions and
apoptosis pathways. Genes targeted by either or both the miR-519 or -520 subfamilies are shown in different color boxes. See Discussion section
for description of the proposed scheme
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expression in the choriocarcinoma JEG-3 cell line regu-
lated by a master promoter [24]. Another studies have
shown that the highly abundant Alu repetitive sequences
embedded within the C19MC genomic region may
function as independent RNA polymerase II promoters
[42, 43]. Our study clearly showed selective C19MC
miRNA activation in MSCs and HWP, and in cancer
cells, suggesting that C19MC transcripts are more likely
regulated by multiple promoters, which may in turn be
active by condition-specific transcription factors. Further-
more in cancer cells, chromosomal rearrangements, ampli-
fication and modification of the promoter(s) or specific
transcription factors could further regulate the selective
C19MC miRNA expression. Previous reports have, indeed,
shown that translocation of chromosomal band 19q13.4 se-
lectively activated C19MC miRNAs in thyroid adenomas,
and that C19MC genomic amplifications in an aggressive
primitive neuroectodermal brain tumors were associated
with specific and abundant expression of miR-517c and
-520g [44]. Moreover, epigenetic alterations in the C19MC
genomic region may also play important role in regulating
C19MC expression, particularly in cancer and the dynamic
stem cells. Promoter silencing of C19MC miRNAs by the
DNA methylation inhibitor, 5-azacytidine, activated sixteen
C19MC miRNAs [45]. Furthermore, placenta-derived
mesenchymal stem cells were reported to escape epigen-
etic silencing of the paternal allele resulting in a number
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Specific activation of the C19MC miR-512-5p by histone
deacetylase inhibitors was also reported in human gastric
cancer cells [43]. Transcription factors acting in trans are
essential regulators of C19MC miRNA expression as
shown by direct binding of p53 and the estrogen receptor
α (ERα) to presumptive promoters of C19MC miR-519d
and miR-515-5p, respectively, in chromatin immunopre-
cipitation assays [47, 48]. As a result of the specific DNA
binding, miR-519d is up-regulated by p53, whereas ERα
mediates both down- and up-regulated expression of
miR-515-5p induced by estrogens and tamoxifen, respect-
ively. Thus, transcription of specific C19MC miRNAs in
MSC and cancer cells is likely highly complex, and may be
dependent on the cellular and pathological state of the
cells.
It was previously reported that C19MC is silenced in
normal tissues [11, 25] due to hypermethylation of both
the paternal and maternal alleles [26]. However, placenta
is able to escape epigenetic silencing by maintaining pater-
nal allele-expression [26, 45]. Moreover, the expression of
miR-498, a member of C19MC, was reported in the fetal
brain [49], echoing our report of Group C miRNAs being
expressed in a fetal colon epithelium-derived cell line,
CRL-1790 and placental Hs799. PI (Fig. 1c), consistent
with C19MC expression in reproductive and develop-
mental process-related tissues, relevant to the primate-
specificity of the C19MC cluster.
In this study, we found that the 3p arms of the C19MC
miRNA precursors were predominantly selected in ESCs
and iPSCs (Table 2 and Fig. 2). Several studies have
previously demonstrated that preferred arm selection is
temporal- and spatial-dependent [50, 51]. Indeed, the
3p miRNA species have been shown to be more abundantly
expressed in tumor tissues as opposed to preferred 5p se-
lection in normal tissues [51]. Echoing these findings, the
miR-302-like C19MC are also predominantly 3p-biased,
possibly targeting genes which are biologically significant in
regulating the stemness of stem cells and the tumor
phenotype in cancers.
Structural and function significance of the group I
C19MC-AAGUGC-miRNAs
Our results also showed divergence in the positions of
the AAGUGC seed sequence among C19MC miRNAs
carrying the hexameric sequence. The canonical seed re-
gion situated at nucleotides 2-7 is a perfect seed match
which markedly decreases the presence of false-positive
bioinformatics predictions, thus improving prediction
reliability [1]. Furthermore, the canonical seed region is
crucial and sufficient to trigger target silencing [1]. The
hexamer of half of the C19MC-AAGUGC-miRNAs re-
ported here are located at nts 2-7, designated as group I
C19MC-AAGUGC-miRNAs in this report (Fig. 2),suggesting high possibility that the predicted genes are the
putative targets. Other non-canonical C19MC-AAGUGC-
miRNAs are likely to have lower affinity and specificity
and may be limited in mediating repression without the
3’-compensatory binding [52].
The group I miRNAs are composed of the miR-519
and -520 subfamilies. Despite their similar seed location
at nts 2-7, Venn diagram analysis shows that these two
subfamilies share only a small number of putative target
genes (Fig. 3a). Common prediction algorithms that use
identical powerful prediction characteristics, such as the
mandatory stringent seed base-pairing produce different
prediction results properly due to usage of various UTR
databases as well as different internal criteria [53]. In this
study, the putative target sets of the miR-519 and -520
subfamilies are overlapping gene sets predicted by two dif-
ferent prediction algorithms. Furthermore, one of the
characteristics of target prediction, the sequence context
surrounding the seed binding site of the target transcript
[1], between the miR-519 and -520 subfamilies are also
dissimilar (Fig. 2a). This may explain the different target
gene sets of these two subfamilies. It has been reported
that miR-96 and -182 that have identical seed region
(UUGGCA, nucleotides 2-7) regulate different targets
[54]. However, the miR-520 and miR-302/372 families
share a significant number of target genes (Fig. 3a) sug-
gesting common biological functions. Hence, it is highly
likely that the group I miR-520 miRNAs may also contrib-
ute to reprogramming, as supported by the predicted in-
volvement of miR-520 miRNAs in the reprogramming-
related apoptosis and cell proliferation pathways (see Fig. 4
and Discussion below).
Regulation of C19MC miRNAs in tumorigenesis and stemness
Selective activation of C19MC miRNAs in MSCs and
cancer cells reported here suggests functional involvement
of the activated miRNAs in maintaining the stemness
and promoting cancer development. Frequent aberrant
C19MC miRNA expression in cancers has been re-
ported [20, 44, 47]. Activation of the C19MC miR-519d
was shown to target CDKN1A/p21, PTEN, AKT3 and
TIMP2, and is closely associated with the pathogenesis
of hepatocellular carcinoma by promoting cell prolifer-
ation and invasion, and in inhibiting apoptosis [47]. In
breast cancer, high expression levels of plasma miR-520g
is correlated with patients with lymph node metastasis
and mammary gland invasion, and suppressed p53 ex-
pression [31].
On the other hands, C19MC miRNAs have also been
shown to play important role in cellular stemness state. In
normal embryonic development, many C19MC miRNAs
have been shown to be expressed only in undifferentiated
or germinal tissues, and C19MC expression inhibits differ-
entiation of human embryonic stem cells [7, 26, 55]. The
Nguyen et al. Journal of Biomedical Science  (2017) 24:20 Page 12 of 14observation that the cellular reprogramming-able tran-
scription factors OCT4 and NANOG regulate C19MC
miRNA expression in human embryonic stem cells further
supports close association of C19MC with induced
pluripotency [56]. Moreover, the identification of six-
teen miR-302-like C19MC miRNAs predicts functions
in promoting “stemness” as the miR-302 and miR-372
families. Similarly, eight miR-302-like C19MC miRNAs
were previously shown to promote cell proliferation
and cell-cycle progression by targeting p21, an inhibitor
of the G1/S transition, as for the miR-302 and -372
families [5, 6].
Possible involvement of group I C19MC-AAGUGC-miRNAs in
regulating the apoptosis pathway common to stemness
and cancer phenotype
Suppressed apoptosis is important to both the initial
phase of acquiring pluripotency and in cancer progression
[57, 58]. A combined expression profile and bioinformat-
ics analysis reported in this work has, indeed, shown that
the group I C19MC-AAGUGC-miRNAs, target genes
related to the survival pathways (Table 4). Based on the
predicted target genes, a scheme that correlates the
group I C19MC-AAGUGC-miRNAs to stemness and
cancer phenotype is proposed (Fig. 4). In general, group
I miRNAs may enhance apoptosis through the PIK3/ATK,
TNFs/NF-κB and TRAIL pathways, as predicted by KEGG
pathway analysis (Fig. 4) [40, 58–60]. The PIK3 pathway is
activated by a wide range of extracellular signals, including
cytokines, e.g. IL-2 [61], growth factors, e.g. IGF1 [60] and
components of the extracellular matrix (ECM) such as
TSP-1 [62], all of which are the predicted targets of the
group I miRNAs (Fig. 4). It is proposed here that the
miRNAs target and inactivate the PIK3/AKT3 pathway
by inhibition of the PIK3-related upstream genes TSP-1,
IL-2, IGF1, KIT, SOS1 and PIK3CA, and the downstream
AKT1 gene. The second important mechanism of cell
survival is tumor necrosis factors (TNFs) activation of
anti-apoptotic proteins via the nuclear factors of kappa B
(NF-κB) signaling cascade (Fig. 4). Similar to the PIK3/
ATK pathway, group I C19MC-AAGUGC- miRNAs
may enhance apoptosis by the predicted targeting of the
TNFα, TLR4, TRAF6, TAK1, NIK, MALT1 and RelA genes.
Thirdly, group I miRNAs are also predicted to silence genes,
such as DcR2, that are inhibitory to the TRAIL-induced
apoptosis pathway, resulting in pro-apoptosis [40]. The
group I miRNAs-modulated pathways subsequently
suppress the activation of downstream effector caspase-3,
-6, and -7, thus inhibiting apoptosis and promoting prolif-
eration [63].
Conclusions
In the present study, the data show selective expression
of C19MC miRNAs in cancer and stem cells, offeringinsights into possible involvement of selective C19MC
miRNAs in regulation of “stemness” and tumorigenesis,
possibly via the cell survival pathways. More specifically, a
subgroup of sixteen C19MC miRNAs has been identified
that shares the same AAGUGC seed sequence as the
reprogramming miR-302/372 family, predicting contri-
bution of the C19MC-AAGUGC-miRNAs to the repro-
graming process. Further elucidation of the biological
functions of C19MC miRNAs, particular the miRNA-
302-like subclass, may lead to potential applications in
more efficient cellular reprogramming and in cancer therapy.
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